Tibial Lead Levels and Erythropoiesis Stimulating Agent Dosing among 75 Patients with End-Stage Kidney Disease

Environ Health Perspect. 2024 Apr;132(4):47702. doi: 10.1289/EHP14199. Epub 2024 Apr 29.

Authors

Voravech Nissaisorakarn¹, Aaron Specht^{2

3}, John Danziger¹

Affiliations

¹ Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
² Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
³ School of Health Sciences, Purdue University, West Lafayette, Indiana, USA.

No abstract available

Publication types

Letter

MeSH terms

Aged
Female
Hematinics* / therapeutic use
Humans
Kidney Failure, Chronic*
Lead* / blood
Male
Middle Aged

Substances

Hematinics
Lead